Dr. Joseph Biederman and colleagues sanctioned for drug industry ties

Dr. Joseph Biederman and colleagues sanctioned for drug industry ties

Joined: April 1st, 2004, 4:56 pm

July 2nd, 2011, 4:09 pm #1

<div style="border-bottom:medium none;text-align:left;border-left:medium none;background-color:transparent;color:#000000;border-top:medium none;border-right:medium none;text-decoration:none;">
BOSTON, July 2 (UPI) -- A child psychiatrist and two colleagues were sanctioned for allegedly taking money from drug companies and not reporting it, officials in Massachusetts said.

After a three-year investigation, Massachusetts General Hospital and Harvard Medical School sanctioned renowned child psychiatrist Dr. Joseph Biederman and colleagues Drs. Thomas Spencer and Timothy Wilens -- although it did not specify the exact nature of their violations, The Boston Globe reported Saturday.

In a letter to coworkers, the three doctors apologized for violating conflict of interest rules, saying the school and hospital "determined that we violated certain requirements."

In 2008, Sen. Charles Grassley, R-Iowa, accused the three doctors of accepting millions of dollars in consulting fees from drug makers from 2002-2007. Grassley also alleged the three for years failed to report much of the income to university officials.

The Globe said it was unable to get a comment from any of the parties of interest, including attorneys representing the doctors.

The investigation was sparked by Grassley's comments. He didn't return a telephone call to the Globe seeking a comment, but he has been critical of the doctor's alleged practices for years.

Other doctors said it is difficult to know if the sanctions are appropriate because Harvard and Mass. General's findings are vague.

"It's hard for me to make that judgment, but this all sounds like a little slap on the wrist,'' said Dr. Jerome Kassirer, a Tufts University School of Medicine professor and critic of cozy relationships between the drug industry and physicians.


Read more: http://www.upi.com/Health_News/2011/07/ ... z1QxsDgV2M</div>
Quote
Like
Share

Joined: April 1st, 2004, 4:56 pm

July 2nd, 2011, 4:11 pm #2

<div><span class="breadcrumb utility"></span></div><div><div><div><div><img border="0" alt="The Boston Globe" src="http://cache.boston.com/bonzai-fba/File-Based_Image_Resource/from_provider_globe.gif" width="105" height="20"> Harvard doctors punished over pay3 accused of not disclosing consulting fees<div><table border="0" cellspacing="0" cellpadding="0"><tr><td><img border="0" alt="" src="http://cache.boston.com/resize/bonzai-fba/Globe_Photo/2011/07/01/1309577557_5670/300h.jpg" width="246" height="300"></td><td></td></tr></table></div><div class="utility"><span>By Liz Kowalczyk </span><div class="cf"></div><span>Globe Staff <span class="listPipe"><font size="1">/</span> July 2, 2011 </span><div class="cf"></div><div class="hide"><div class="innerContainer"><img alt="" src="http://cache.boston.com/universal/site_graphics/etaf/pointer_top.gif"><div class="titleBar">E-mail this article<a></a>http://www.boston.com/news/local/massachusetts/articles/2011/07/02/three_harvard_psychiatrists_are_sanctioned_over_consulting_fees/ type=hidden name=story_url> To: Add a personal message:<em>(80 character limit)</em> Your E-mail: <div class="cf"></div><div class="sendingArticle">Your article has been sent.</div><img alt="" src="http://cache.boston.com/universal/site_graphics/etaf/pointer_bottom.gif"></div><div><span class="articleTextsize">Text size <span class="minus"><span class="imageLink"><strong></font></strong></span></span> <span class="plus"><span class="imageLink"><strong><font color="#ffffff">+</strong></span></span> </span></div></div></div></div><div><div><div class="firstGraph">
Concluding a three-year investigation, Massachusetts General Hospital and Harvard Medical School sanctioned renowned child psychiatrist Dr. Joseph Biederman and two colleagues after finding they violated conflict of interest rules.
</div><div class="articlePluckHidden"><div><div class="embed"><div class="three outset"></div></div>
In a letter to coworkers yesterday, Biederman and Drs. Thomas Spencer and Timothy Wilens said the hospital and medical school have determined that we violated certain requirements of the institutions policies.
</div><div class="articlePluckHidden">
They did not specify the nature of the violations. But in 2008, Senator Charles Grassley, an Iowa Republican, accused the three doctors of accepting millions of dollars in consulting fees from drug makers from 2000 to 2007, and of failing for years to report much of the income to university officials.
</div><div class="articlePluckHidden">
Officials at Harvard and Mass. General released the letter to the Globe, but would not answer questions about the probe. Biederman, Spencer, Wilens, and their lawyers did not return phone calls and e-mails. Grassleys office did not return calls seeking comment.
</div><div class="articlePluckHidden">
Physicians are required to disclose payments from pharmaceutical and medical device companies so that hospital and university officials can police potential conflicts of interest that may create bias in research or in the treatment of patients, or the appearance of bias.
</div><div class="articlePluckHidden">
Grassleys investigation sparked the Mass. General and Harvard inquiries.
</div><div class="articlePluckHidden">
The three psychiatrists apologized in their letter for the unfavorable attention that this matter has brought to these two institutions. They called their mistakes honest ones but said they now recognize that we should have devoted more time and attention to the detailed requirements of these policies and to their underlying objectives.
</div><div class="articlePluckHidden">
They said the institutions imposed remedial actions, requiring them to refrain from all paid industry-sponsored outside activities for one year, with an additional two-year monitoring period during which they must obtain approval before engaging in paid activities. They were also required to undergo unspecified additional training and suffer a delay of consideration for promotion or advancement.
</div><div class="articlePluckHidden">
Physicians said it is difficult to know if the sanctions are appropriate without knowing the Harvard and Mass. General findings.
</div><div class="articlePluckHidden">
Its hard for me to make that judgment, but this all sounds like a little slap on the wrist, said Dr. Jerome Kassirer, a Tufts University School of Medicine professor and outspoken critic of close ties between the drug industry and physicians. He pointed out that Biederman is a full professor at Harvard Medical School, so its unclear how a delay in promotion or advancement would affect him. Also, Biederman severed his industry ties soon after Mass. General and Harvard began their separate but coordinated investigations.
</div><div class="articlePluckHidden">
But Dr. Benjamin Liptzin, chairman of psychiatry at Baystate Medical Center in Springfield, said he believes the actions send a serious message that the hospital and medical school take this seriously.
</div><div class="articlePluckHidden">
Doctors agreed that since the mid-2000s physicians, particularly psychiatrists, are more cautious about taking money from drug companies, and about disclosing the money they do earn. Responding in part to public distrust, hospitals and universities - including Mass. General and Harvard - have further limited how much money doctors can accept and are more stringently enforcing disclosure requirements.
</div><div class="articlePluckHidden">
Biederman is the countrys most prominent advocate of diagnosing bipolar disorder in children, even in those under age 6, and using antipsychotic drugs to treat many of them. He became one of the central figures in the growing legal and political backlash against potential conflicts of interest in medicine.
</div><div class="articlePluckHidden">
Congressional investigators led by Grassley accused Biederman, Spencer, and Wilens of failing to disclose more than $1 million each in payments they received from industry over the eight years. In addition, documents in a lawsuit portrayed Biederman as courting drug company money by promising that his work at Mass. General would help promote the use of antipsychotic drugs for youngsters - a characterization Biederman has said is untrue.
</div><div class="articlePluckHidden">
Liptzin said that, during those years, it was common for companies to fund clinical trials of psychiatric drugs and then hire the physician investigator as a consultant to speak about the results across the country.
</div><div class="articlePluckHidden">
Its very seductive because doctors were able to make substantial money, he said. Liptzin said he became uneasy when, after giving talks, drug sales people would tell him you could have made more nice statements about the drug.
</div><div class="articlePluckHidden">
Now, he said, far fewer doctors accept payments, and those that do are far more careful about disclosure. People understand that we need to be as objective as possible in advancing our knowledge.
</div><div class="articlePluckHidden">
Dr. Daniel Carlat, a psychiatrist, Tufts medical school professor, and critic of the drug industry, said it was almost expected that if you were an academic that you were working with industry.
</div><div class="articlePluckHidden">
If you were at a very high level institution like Harvard, there was almost a sense that you were entitled to receive a lot of perks and money for various activities from industry, he said.
</div><div class="articlePluckHidden">
When I get on the phone now and talk to a colleague about a study that just came out, there is much more talk about, Was this industry funded, and can we trust the study?
</div><div class="articlePluckHidden">
<em>Liz Kowalczyk can be reached at [url=mailto:kowalczyk@globe.com]kowalczyk@globe.com[/url]. </em><img border="0" alt="" src="http://cache.boston.com/bonzai-fba/File-Based_Image_Resource/dingbat_story_end_icon.gif" width="6" height="8">
</div></div></div></div></div>
Quote
Like
Share